Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease

NCT04769648 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Graft-versus-host Disease

Interventions

DRUG: Pro-ocular™ Topical Gel 1%
DRUG: Placebo

Sponsor

Glia, LLC